This is the first paper to report that DFX has the ability to suppress tumour proliferation (as we have previously reported), as well as to reduce the abilities of pancreatic cancer cells to change shape and migrate by reducing the activation of Rac1 and Cdc42, Rho-family G proteins involved in cancer invasion. Here, CDC42 is linked to familial pancreatic carcinoma.